BeiGene, Ltd. (NASDAQ:BGNE) Q1 2025 Earnings Call Transcript
Dan Maller: [Abrupt Start]…our Investor Relations website, along with our earnings release.
Posts Tagged ‘NASDAQ:BGNE’
BeiGene, Ltd. (NASDAQ:BGNE) Q4 2024 Earnings Call Transcript
Operator: Good day, everyone. Welcome to BeiGene's Q4 and Full Year 2024 Earnings Call Webcast. All lines have been placed on mute to prevent any background noise.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Here’s Why BeiGene, Ltd. (BGNE) Rallied in Q3
Baird Asset Management controlled Chautauqua Capital Management, a boutique investment firm, released the “Baird Chautauqua International and Global Growth Fund” third quarter...
5 Most Promising Stocks to Buy Before They Take Off
In this article, we discuss the 5 most promising stocks to buy before they take off.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
10 Blue-Chip Stocks At 52-Week Lows
In this piece, we will take a look at the ten blue chip stocks at 52 week lows.
12 High Growth International Stocks to Buy
In this article, we discuss the 12 high growth international stocks to buy.
5 Best High Growth Healthcare Stocks to Buy
In this article, we will take a look at the 5 high growth healthcare stocks to buy.
5 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 5 most promising healthcare stocks according to analysts.
5 Youngest Hedge Fund Billionaires and Their Top Stock Picks
In this article, we discuss the 5 youngest hedge fund billionaires and their top stock picks.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
Ray Dalio on Potential US-China War and Rise of China
In this article, we discuss Ray Dalio on potential US China war and rise of China.
12 Best Fast Growth Stocks to Buy Now
Growth stocks were hammered in 2022 as inflation started to spike and the Federal Reserve began to increase interest rates.
12 Best Fast Growth Stocks to Buy Now
Growth stocks were hammered in 2022 as inflation started to spike and the Federal Reserve began to increase interest rates.
5 Most Promising Cancer Stocks According to Analysts
In this article, we discuss 5 most promising cancer stocks according to analysts.
12 High Growth Healthcare Stocks to Buy
The healthcare sector proved its mettle in 2022.
10 Healthcare Stocks Making Moves After Earnings
In this article, we will take a look at the 10 healthcare stocks making moves after earnings.
Is BeiGene (BGNE) a Smart Long-Term Investment?
Longleaf Partners Fund, a Memphis-based fund under Southeastern Asset Management, published its “Longleaf Partners Asia Pacific UCITS Fund” first quarter 2022 investor letter...
Top Chinese Companies on NASDAQ
There were 261 Chinese firms listed on the three largest US exchanges, namely the New York Stock Exchange, NASDAQ, and NYSE American, as of March 31, 2022.
These 5 Stocks Are Getting Crushed Today
In this article, we take a look at five stocks that are declining today.
10 Best Non-Tech Chinese Stocks to Buy Now
In this article, we discuss the 10 best non-tech Chinese stocks to buy now.
Campbell Wilson’s Old Well Partners Is Buying These 5 Stocks
In this article, we discuss the 5 stocks that Campbell Wilson's Old Well Partners is buying.
5 Biotech Stocks To Buy According To Chinese Billionaire Lei Zhang
In this article, we discuss 5 biotech stocks to buy according to Chinese billionaire Lei Zhang.
Top 5 Stock Picks of Chinese Billionaire Lei Zhang
In this article, we discuss the top 5 stock picks of the Chinese billionaire Lei Zhang.
10 Best China Stocks to Buy Now
In this article, we will discuss the 10 best China stocks to buy now.
Hedge Funds Are Warming Up To BeiGene, Ltd. (BGNE)
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity...
Analysts are Cutting Price Targets of These 10 Stocks
In this article, we discuss the 10 stocks that analysts are cutting price targets of.
Why These 10 Stocks Are On the Move on Friday
In this article we will take a look at the some of notable stocks on the move today.
5 Best Stocks to Invest In According to Chinese Billionaire Lei Zhang
In this article, we will discuss 5 best stocks to invest in according to Chinese billionaire Lei Zhang.
BeiGene, Ltd. (BGNE) Fell Out Of Favor With Hedge Funds
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
5 Best Stocks to Buy According to Billionaire Zhang Lei
In this article, we discuss the 5 best stocks to buy according to billionaire Zhang Lei.
10 Best Hong Kong Stocks To Buy For 2021
In this article, we discussed Chinese billionaire Zhang Lei's investment philosophy and his 10 best Hong Kong stocks to buy for 2021.
5 Best Hong Kong Stocks To Buy For 2021
Below are the 5 best Hong Kong stocks to buy for 2021.
Is BGNE A Good Stock To Buy Now?
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Hedge Fund and Insider Trading News: David Tepper, David Einhorn, Carl Icahn, Alan Howard, Coatue Management, Algebris Investments, Sarissa Capital, Colliers International Group Inc (CIGI), Beigene Ltd (BGNE), and More
Billionaire David Tepper has returned to New Jersey -- a move that may cost him $120 million in state income taxes this year.
Is BeiGene, Ltd. (BGNE) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Hedge Funds Are Betting On BeiGene, Ltd. (BGNE)
We hate to say this but, we told you so.
These Hedge Funds Cashed Out Of BeiGene, Ltd. (BGNE) Too Early
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
Were Hedge Funds Right About Dumping BeiGene, Ltd. (BGNE)?
Is BeiGene, Ltd. (NASDAQ:BGNE) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Here’s What Hedge Funds Think About BeiGene, Ltd. (BGNE)
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.
Here’s What Hedge Funds Think About BeiGene, Ltd. (BGNE)
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive...
Is BeiGene, Ltd. (BGNE) Going to Burn These Hedge Funds?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Hedge Fund and Insider Trading News: Steven Cohen, Carl Icahn, Beigene Ltd (BGNE), Brooks Automation, Inc (BRKS), and More
After a cohort of hedge fund veterans called it quits last year, a trio of established managers are prepping to fill their shoes in 2018 by starting firms with at least a billion...
13D Filing: Baker Bros. Advisors and Beigene Ltd (ADR) (BGNE)
Please follow Baker Bros. Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Baker Bros.
13D Filing: Baker Bros. Advisors and Beigene Ltd (ADR) (BGNE)
You can access the original SEC filing by clicking here.
Beigene Ltd (ADR) (BGNE): Here’s Our Take
Beigene Ltd (ADR) (NASDAQ:BGNE) had a pretty tough time throughout the latter half of November and early to mid December.
Hedge Funds’ Favorite Recently-Public Companies amid Atrophied IPO Market
There was not a single initial public offering in January and the U.S. IPO market has almost evaporated in 2016.
